Literature DB >> 20171522

Radiation dose-volume effects in the heart.

Giovanna Gagliardi1, Louis S Constine, Vitali Moiseenko, Candace Correa, Lori J Pierce, Aaron M Allen, Lawrence B Marks.   

Abstract

The literature is reviewed to identify the main clinical and dose-volume predictors for acute and late radiation-induced heart disease. A clear quantitative dose and/or volume dependence for most cardiac toxicity has not yet been shown, primarily because of the scarcity of the data. Several clinical factors, such as age, comorbidities and doxorubicin use, appear to increase the risk of injury. The existing dose-volume data is presented, as well as suggestions for future investigations to better define radiation-induced cardiac injury. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171522     DOI: 10.1016/j.ijrobp.2009.04.093

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  198 in total

1.  Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.

Authors:  Youlia M Kirova; Cyrus Chargari
Journal:  World J Radiol       Date:  2011-03-28

2.  Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.

Authors:  Amode R Tembhekar; Cari L Wright; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2016-12-22       Impact factor: 4.785

Review 3.  Cardiac toxicity of lung cancer radiotherapy.

Authors:  Radovan Vojtíšek
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-14

4.  Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.

Authors:  Jan Kriz; Max Spickermann; Philipp Lehrich; Heinz Schmidberger; Gabriele Reinartz; Hans Eich; Uwe Haverkamp
Journal:  Strahlenther Onkol       Date:  2015-04-16       Impact factor: 3.621

5.  Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.

Authors:  Michael T Milano; Huilin Li; Mitchell H Gail; Louis S Constine; Lois B Travis
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

6.  Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed?

Authors:  Jan Wondergem; Marjan Boerma; Kazunori Kodama; Fiona A Stewart; Klaus R Trott
Journal:  Radiat Environ Biophys       Date:  2013-09-03       Impact factor: 1.925

7.  Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.

Authors:  A Botticella; G Defraene; K Nackaerts; C Deroose; J Coolen; P Nafteux; B Vanstraelen; S Joosten; L A W Michiels; S Peeters; D De Ruysscher
Journal:  Strahlenther Onkol       Date:  2017-02-14       Impact factor: 3.621

8.  Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.

Authors:  Lu Cao; Gang Cai; Cai Chang; Ai-Yu Miao; Xiao-Li Yu; Zhao-Zhi Yang; Jin-Li Ma; Qian Zhang; Jiong Wu; Xiao-Mao Guo; Jia-Yi Chen
Journal:  Oncologist       Date:  2015-05-01

9.  Effect of Bra Use during Radiotherapy for Large-Breasted Women: Acute Toxicity and Treated Heart and Lung Volumes.

Authors:  Lanea Keller; Randi Cohen; Dennis M Sopka; Tianyu Li; Linna Li; Penny R Anderson; Barbara L Fowble; Gary M Freedman
Journal:  Pract Radiat Oncol       Date:  2013-01-05

10.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.